Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Outlook Business
outlookbusiness.com > corporate > astrazeneca-bristol-myers-in-early-talks-for-potential-400-bn-pharma-merger

AstraZeneca, Bristol Myers in Early Talks for Potential $400 Bn Pharma Merger – Outlook Business

1+ hour, 36+ min ago   (554+ words) The two drugmakers held preliminary discussions on a possible merger, though any deal could face significant antitrust scrutiny in the US AstraZeneca and Bristol Myers Squibb held preliminary talks about a potential merger. A combined company would be valued at…...